These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9520174)

  • 21. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities.
    Vandebosch A; Goetghebeur E; Ramjee G; Alary M; Ettiègne-Traoré V; Chandeying V; Van Damme L;
    Sex Transm Infect; 2004 Jun; 80(3):241-3. PubMed ID: 15170013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
    Weir SS; Roddy RE; Zekeng L; Feldblum PJ
    Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
    Mauck CK; Weiner DH; Ballagh SA; Creinin MD; Archer DF; Schwartz JL; Pymar HC; Lai JJ; Rencher WF; Callahan MM;
    Contraception; 2004 Jul; 70(1):77-83. PubMed ID: 15208057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonoxynol-9 does not protect against HIV.
    AIDS Patient Care STDS; 2008 Jan; 22(1):89-93. PubMed ID: 18442307
    [No Abstract]   [Full Text] [Related]  

  • 25. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
    Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
    Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and toxicity of nonoxynol-9 gel as a rectal microbicide.
    Tabet SR; Surawicz C; Horton S; Paradise M; Coletti AS; Gross M; Fleming TR; Buchbinder S; Haggitt RC; Levine H; Kelly CW; Celum CL
    Sex Transm Dis; 1999 Nov; 26(10):564-71. PubMed ID: 10560720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
    Poynten IM; Millwood IY; Falster MO; Law MG; Andresen DN; Van Damme L; Kaldor JM
    AIDS; 2009 Jun; 23(10):1245-54. PubMed ID: 19474652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers.
    Jespers VA; Van Roey JM; Beets GI; Buvé AM
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):154-8. PubMed ID: 17106275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
    Mauck CK; Lai JJ; Weiner DH; Chandra N; Fichorova RN; Dezzutti CS; Hillier SL; Archer DF; Creinin MD; Schwartz JL; Callahan MM; Doncel GF
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dosing study of nonoxynol-9 and genital irritation.
    Roddy RE; Cordero M; Cordero C; Fortney JA
    Int J STD AIDS; 1993; 4(3):165-70. PubMed ID: 8391856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men.
    Wilkinson D; Ramjee G; Tholandi M; Rutherford G
    Cochrane Database Syst Rev; 2002; (4):CD003939. PubMed ID: 12519623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of spermicides on vulvar, vaginal, and cervical mucosa.
    Poindexter AN; Levine H; Sangi-Haghpeykar H; Frank ML; Grear A; Reeves KO
    Contraception; 1996 Mar; 53(3):147-53. PubMed ID: 8689878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-9 film study a blow for microbicide research.
    AIDS Alert; 1997 Jun; 12(6):66-8. PubMed ID: 11364359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.
    Wilkinson D; Tholandi M; Ramjee G; Rutherford GW
    Lancet Infect Dis; 2002 Oct; 2(10):613-7. PubMed ID: 12383611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of nonoxynol-9 from an in vivo point of view.
    Wittkowski KM
    AIDS; 1997 Mar; 11(3):392-4. PubMed ID: 9147438
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of 'anti-HIV' spermicide may increase infection risk.
    Nature; 2002 Jul; 418(6893):9. PubMed ID: 12097878
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of biopsy in vaginal microbicide development.
    Low-Beer N
    J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3():S181-3. PubMed ID: 16419270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model.
    Patton DL; Kidder GG; Sweeney YC; Rabe LK; Clark AM; Hillier SL
    Sex Transm Dis; 1996; 23(6):461-4. PubMed ID: 8946629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fourteen-day safety and acceptability study of the universal placebo gel.
    Schwartz JL; Ballagh SA; Kwok C; Mauck CK; Weiner DH; Rencher WF; Callahan MM
    Contraception; 2007 Feb; 75(2):136-41. PubMed ID: 17241844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.